The following is a summary of "Comparison of prognostic scores according to WHO classification in 170 patients with advanced ...

Cogent Biosciences' uncertain competitive edge may compel investors to sit on the sidelines. Read more about the cautious ...

A standard treatment for mastocytosis is difficult to apply to individual patients based on the variable clinical course. A general consensus for using antimediator agents such as antihistamines ...

Blueprint Medicines' AYVAKIT continues to gain traction among key stakeholders. See more on BPMC stock and the factors ...

After hours: September 30 at 7:36 PM EDT Loading Chart for BPMC ...

Allakos (ALLK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jonathan ...

After hours: September 26 at 5:43 PM EDT Loading Chart for COGT ...

In the final episode, experts at UCSD and La Jolla Institute discuss current clinical trials of a cancer vaccine and future directions for neoantigen vaccines. Custom-made Cancer Therapy ...